Pulmonary embolism (PE) and deep vein thrombosis (DVT), collectively known as venous thromboembolism (VTE), present a major health challenge that affects 350,000 to 600,000 Americans each year. Symptomatic PE and DVT are associated with increased length of stay and mortality rates between 10 percent and 15 percent. Evidence-based thromboprophylaxis for at-risk patients can reduce VTE by 30 percent to 65 percent, according to the Agency for Healthcare Research and Quality (AHRQ).
Reduction in VTE is part of HealthInsight’s commitment to reducing patient harm by 20 percent over the next two years. HealthInsight’s plan for assisting hospitals in reducing VTEs will include providing technical assistance, self-assessment tools, educational webinars and conferences, and links to evidence-based best practices surrounding VTE prevention.